Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Mayo Clinic invests $432M in Florida hospital expansion project

The health system has seen "unprecedented growth” in Florida in recent years, spurring a 23% increase in staffing. 

Thumbnail

Population growth drives new hospital construction in North Carolina

The addition is part of Atrium Health’s $1 billion expansion plans.

2022 year

From the Great Resignation to PET/CT, 9 trends driving diagnostic imaging in 2022

“These trends represent the business, market, and technology dynamics that imaging leaders cannot afford to ignore,” Alliance Healthcare Services reported recently. 

Thumbnail

Lawsuit targets hospital system’s ‘astonishingly high’ charges for CT imaging and other care

Vidant Health has allegedly hid prices from patients, allowing it to overcharge for computed tomography exams and other common procedures, attorneys charged.

Thumbnail

Mortality odds increase in older, financially stressed patients following a heart attack

Severe financial stress was associated with a 61% increase in 180-day mortality risk in individuals following acute myocardial infarction.

mergers and acquisitions M&A puzzle

6 common pitfalls to avoid when consummating a radiology M&A deal

“Mergers and acquisitions can work, but only if everyone involved truly knows what they are doing," experts wrote in the Journal of the American College of Radiology

95% of doctors believe COVID-19 has exposed cracks in the medicine supply chain

Sixty-two percent of those surveyed believe significant reliance on other countries for medicines is among the biggest contributing factor to medicine shortages, according to new survey results.

Thumbnail

MindMaze secures $105 million to expand commercial growth

The financing was led by Concord Health Partners in conjunction with AlbaCore Capital Group and London-based Hambro Perks.